Neos Therapeutics, Inc.

CIK 1467652 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Neos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 30, 202115-12B0001213900-21-018394
Mar 25, 2021EFFECT9999999995-21-001122
Mar 25, 2021EFFECT9999999995-21-001123
Mar 25, 2021EFFECT9999999995-21-001120
Mar 25, 2021EFFECT9999999995-21-001121
Mar 22, 20218-K0001213900-21-016770
Mar 22, 20214250001213900-21-016771
Mar 19, 2021S-8 POS0001213900-21-016665
Mar 19, 202140001104659-21-039223
Mar 19, 2021POS AM0001213900-21-016650
Mar 19, 2021POS AM0001213900-21-016656
Mar 19, 2021S-8 POS0001213900-21-016668
Mar 19, 202140001104659-21-039264
Mar 19, 2021S-8 POS0001213900-21-016681
Mar 19, 202140001104659-21-039230
Mar 19, 2021POS AM0001213900-21-016654
Mar 19, 202140001104659-21-039225
Mar 19, 202140001104659-21-039226
Mar 19, 2021S-8 POS0001213900-21-016676
Mar 19, 202140001104659-21-039174
Mar 19, 202140001104659-21-039224
Mar 19, 202140001104659-21-039228
Mar 19, 202140001104659-21-039210
Mar 19, 2021S-8 POS0001213900-21-016678
Mar 19, 2021POS AM0001213900-21-016658